Cara Therapeutics, Inc. (CARA) Social Stream
CARA THERAPEUTICS INC (CARA) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering CARA THERAPEUTICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 8 | $35 | $16 | $26.125 | $0.665 | 3828.57% |
| 2021-11-28 | 8 | $35 | $17 | $26.25 | $0.665 | 3847.37% |
| 2022-02-02 | 7 | $35 | $17.001 | $26.25 | $0.665 | 3847.37% |
| 2022-03-02 | 8 | $35 | $15 | $25.875 | $0.665 | 3790.98% |
| 2022-03-08 | 8 | $35 | $15 | $26.25 | $0.665 | 3847.37% |
| 2022-04-06 | 8 | $33 | $15 | $25.428 | $0.665 | 3723.76% |
| 2022-05-09 | 7 | $33 | $15 | $25.428 | $0.665 | 3723.76% |
| 2022-05-16 | 7 | $33 | $13 | $24.571 | $0.665 | 3594.89% |
| 2022-10-10 | 7 | $33 | $13 | $24.714 | $0.665 | 3616.39% |
| 2023-02-09 | 6 | $30 | $13 | $22.333 | $0.665 | 3258.35% |
| 2023-02-16 | 6 | $28 | $13 | $21.5 | $0.665 | 3133.08% |
| 2023-03-07 | 6 | $28 | $13 | $19.6 | $0.665 | 2847.37% |
| 2023-03-27 | 7 | $28 | $6 | $18 | $0.665 | 2606.77% |
| 2023-05-15 | 8 | $28 | $6 | $18.5 | $0.665 | 2681.95% |
| 2023-07-17 | 8 | $28 | $4 | $17.625 | $0.665 | 2550.38% |
| 2023-08-07 | 8 | $25 | $4 | $17.25 | $0.665 | 2493.98% |
| 2023-08-08 | 8 | $25 | $3.5 | $17.062 | $0.665 | 2465.71% |
| 2023-08-09 | 8 | $25 | $3.5 | $16.812 | $0.665 | 2428.12% |
| 2023-08-25 | 8 | $25 | $3 | $16.75 | $0.665 | 2418.8% |
| 2023-09-07 | 8 | $25 | $3 | $15.5 | $0.665 | 2230.83% |
| 2023-10-20 | 8 | $25 | $3 | $14.5 | $0.665 | 2080.45% |
| 2023-11-02 | 8 | $23 | $3 | $13.875 | $0.665 | 1986.47% |
| 2023-11-13 | 8 | $23 | $1 | $12.5 | $0.665 | 1779.7% |
| 2023-11-14 | 7 | $22 | $1 | $12.143 | $0.665 | 1726.02% |
| 2023-12-19 | 7 | $22 | $1 | $10.071 | $0.665 | 1414.44% |
The Trend in the Analyst Price Target
Over the past 20 months, CARA's average price target has gone down $16.79.
CARA reports an average of 534.53% for its upside potential over the past 47 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-26 | 6 | 30 | 13.0 | 22.333 | 12.27 | 82.01% |
| 2023-03-07 | 6 | 28 | 18.0 | 22.000 | 6.69 | 228.85% |
| 2023-04-04 | 8 | 28 | 6.0 | 18.500 | 4.74 | 290.3% |
| 2023-08-09 | 8 | 25 | 3.5 | 16.812 | 3.02 | 456.69% |
| 2023-10-20 | 8 | 25 | 3.0 | 14.500 | 1.29 | 1024.03% |
CARA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.43 | 5 | 1 | 1 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
CARA's average broker recommendation rating improved by 0.32 over the prior 29 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, CARA THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 3369.35% of them.
- In the context of all US stocks, CARA THERAPEUTICS INC's variance in analysts' estimates is lower than -2814.27% of them.
- In terms of how CARA THERAPEUTICS INC fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is greater than 2869.96% of that group.
- In the context of Healthcare stocks, CARA THERAPEUTICS INC's average analyst price target is greater than 1156.02% of them.
In the Pharmaceutical Products industry, OCUL, ARDX, and ARCT are the three stocks most similar to CARA THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for CARA? Use POWR Ratings for clearer insight into price direction.